4//SEC Filing
ESBER HENRY JEMIL 4
Accession 0001415889-18-000329
CIK 0001411879other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 3:03 PM ET
Size
8.4 KB
Accession
0001415889-18-000329
Insider Transaction Report
Form 4
ESBER HENRY JEMIL
Director
Transactions
- Award
Restricted Stock Units
2018-02-23$0.08/sh+71,856$6,000→ 2,099,231 totalFrom: 2018-02-23Exp: 2028-02-23→ Common Stock (71,856 underlying) - Award
Restricted Stock Units
2018-02-23$0.18/sh+500,000$89,500→ 2,599,231 totalExp: 2028-02-23→ Common Stock (500,000 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents the contingent right to receive, at settlement, one share of common stock.
- [F2]The Reporting Person was granted a Restricted Stock Unit on February 23, 2018 of 35,928 shares, which were fully vested on the date of the grant. The RSU is for the Reporting Person's quarterly compensation as a member of the Board of Directors for the fourth quarter of 2017 and was valued on December 31, 2017 in accordance with the approved compensation plan for the non-employee members of the Board of Directors.
- [F3]These restricted stock units were granted pursuant to the Issuer's Amended and Restated 2016 Equity Incentive Plan.
- [F4]RSU was granted on February 23, 2018. 125,000 RSUs vest on February 23, 2019; the total remaining shares vest in eight (8) pro rata equal installments, quarterly for two (2) years thereafter, subject to continued service.
Documents
Issuer
INNOVUS PHARMACEUTICALS, INC.
CIK 0001411879
Entity typeother
Related Parties
1- filerCIK 0001391501
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 3:03 PM ET
- Size
- 8.4 KB